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Sciences and ChinesAbstract A novel method for the simultaneous high-performance liquid chromatographic determi-
nation of nortriptyline hydrochloride and ﬂuphenazine hydrochloride was developed and validated.
Fluvastatin sodium was used as internal standard. The determination was performed on a Hypersil Gold
C8 column (250 mm  4.6 mm i.d., 5 mm particle size) at 25 1C; the mobile phase, consisting of a mixture
of formic acid (0.1 M, pH 2.16)-methanol (33:67, v/v), was delivered at a ﬂow rate of 1.1 mL/min and
detector wavelength at 251 nm. The retention time of nortriptyline, ﬂuphenazine and ﬂuvastatin was
found to be 5.11, 8.05 and 11.38 min, respectively. Linearity ranges were 5.0–1350.0 and 10.0–1350.0 mg/
mL with limit of detection values of 0.72 and 0.31 mg/mL, for nortriptyline and ﬂuphenazine, respectively.
Results of assay and recovery studies were statistically evaluated for its accuracy and precision.
Correlation coefﬁcients (r2) of the regression equations were greater than 0.999 in all cases. According
to the validation results, the proposed method was found to be speciﬁc, accurate, precise and could be
applied to the simultaneous quantitative analysis of nortriptyline and ﬂuphenazine.
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Nortriptyline, 3-(10, 11-dihydro-5H-dibenzo [a,d] cyclohepten-
5-ylidene)-N-methyl-1-propanamine, is a tricyclic antidepressant
drug widely used in the treatment of unipolar depression, since
it is a non-selective serotonine uptake inhibitor [1]. Fluphen-
azine, 2-[4-[3-[2-(triﬂuoromethyl)-10H-phenothiazin-10-yl] propyl]
piperazin-1-yl] ethanol dihydrochloride, is an antipsychotic drug
in the phenothiazine class of compounds. The N-alkyl side chain
is modiﬁed from a base phenothiazine structure [2].
Literature survey reveals that both nortriptyline hydrochloride
and ﬂuphenazine hydrochloride are ofﬁcial in Britishlsevier B.V. All rights reserved.
S. Ashour, N. Kattan438Pharmacopeia [2]. Few chromatographic methods for the deter-
mination of nortriptyline hydrochloride and ﬂuphenazine hydro-
chloride in pharmaceutical preparations [3,4] or with other active
ingredients [5] have been reported. Other techniques for the
determination of the latter compounds in different pharmaceutical
preparations have been developed including spectrophotometry
[4,6–8], polymeric membrane electrodes [9], electrochemical [10]
and HPTLC [11]. An increasing number of publications are
appearing describing a chromatographic methods for the determi-
nation of nortriptyline hydrochloride and ﬂuphenazine hydro-
chloride with other active ingredients in biological samples [12–20].
The purpose of the current study was to develop a sensitive,
accurate and comparatively simple method for simultaneous
quantiﬁcation of nortriptyline hydrochloride and ﬂuphenazine
hydrochloride in raw materials and pharmaceutical formula-
tions by HPLC.
2. Experimental
2.1. Materials
Working reference standards of nortriptyline hydrochloride
(NOR), ﬂuphenazine hydrochloride (FLU) and ﬂuvastatin
sodium (FVS) were supplied by Vasudha Pharma Chem Limited,
Centaur Chemicals Private Limited (India) and Zhejiang Materi-
als Industry Chemical Group Co., Ltd. (China), respectively.
The structures of these compounds are shown in Fig. 1. Meth-
anol and water (HPLC grade) were purchased from Labscan
(Ireland). Formic acid (analytical grade) was purchased from
Surechem Products Ltd. (England). Tablets were purchased from
Syrian market, containing nortriptyline hydrochloride 10 mg and
ﬂuphenazine hydrochloride 0.5 mg per tablet.
2.2. HPLC system
The chromatographic system consisted of Hitachi (Japan) model
L-2000 equipped with a binary pump (model L-2130, ﬂow rate
range 0.000–9.999 mL/min), degasser and a column oven (model
L-2350, temperature range 1–85 1C). All samples were injected
(10 mL) using a Hitachi L-2200 autosampler (injection volume
range 0.1–100 mL). Elutions of all analytes were monitored at
251 nm using a Hitachi L-2455 absorbance detector (190–
900 nm) containing a quartz ﬂow cell (10 mm path and 13 mL
volume). Each chromatogram was analyzed and integrated
automatically using the Ezchrom Elite Hitachi Software.
2.3. Chromatographic conditions
Separation was achieved on a reversed phase Hypersil Gold C8
column (250 mm  4.6 mm, 5 mm particle size, ThermoFluphenazine hydroc
(C22H26F3N3OS. 2HCl =5
Nortriptyline hydrochloride
(C19H21N. HCl =299.8g/mole)
Figure 1 Chemical structure of nortriptyline hydrochloride,Germany) at 25 1C. The mobile phase was a mixture of
methanol and 0.1 M formic acid (67:33, v/v) with a ﬂow rate
of 1.1 mL/min and was ﬁltered and degassed by ultrasonic
agitation before use. The injection volume was 10 mL.2.4. Standard solutions
Standard stock solutions of nortriptyline hydrochloride
(3.0 mg/mL) and ﬂuphenazine hydrochloride (3.0 mg/mL)
were prepared by direct weighing of standard substance with
subsequent dissolution in methanol. Stock standard solution
of ﬂuvastatin sodium (1.0 mg/mL) was prepared by dissolving
appropriate amount of the compound in methanol. These
solutions were stored in the dark at 2–8 1C and found to be
stable for three weeks at least.2.5. Calibration graphs
A series of working standard drug solutions equivalent to 5.0–
1350.0 mg/mL for NOR and 10.0–1350.0 mg/mL for FLU were
prepared by diluting the stock standard solution with the
methanol. In each sample 1 mL of FVS was added (100 mg/mL
in the ﬁnal volume). To construct the calibration curve ﬁve
replicates (10 mL) of each standard solution were injected
immediately after preparation into the column and the peak
area of the chromatograms was measured. Then, the mean
peak area ratio of NOR and FLU to that of the internal
standard was plotted against the corresponding concentration
to obtain the calibration graph.2.6. Assay procedure for dosage forms
Twenty tablets containing NOR and FLU were weighed and
ﬁnely powdered. Portions of the powder (each equivalent to the
weight of ﬁve tablets) were accurately weighed into 50 mL
volumetric ﬂasks and 30 mL methanol was added. The volumetric
ﬂasks were sonicated for 15 min to effect complete dissolution of
NOR and FLU, the solutions were then made up to volume with
methanol. The sample solutions were ﬁltered through 0.45 mm
nylon ﬁlter. The aliquot portions of the ﬁltrate were further diluted
to get a ﬁnal concentration of 900 mg/mL of NOR and 45 mg/mL
of FLU in the presence of 100 mg/mL of internal standard.
Finally, 10 mL of each diluted sample was injected into the column
and chromatogram was recorded. Peak area ratios of NOR and
FLU to that of FVS were then measured for the determination.
NOR and FLU concentrations in the samples were then calcu-
lated using peak data and standard curves.hloride
10.5g/mole)
Fluvastatin sodium
(C24H25FNO4Na =433.46 g/mole)
ﬂuphenazine hydrochloride and ﬂuvastatin sodium (I.S.).
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Figure 2 A typical chromatogram of a mixture of NOR (75 mg/mL), FLU (75 mg/mL) and FVS (100 mg/mL) at retention times 5.113,
8.053 and 11.380 min, respectively. Chromatographic conditions: RP-HPLC on C8 column; mobile phase: formic acid (0.1 M, pH 2.16)
and methanol (33:67, v/v); ﬂow rate 1.1 mL/min and detection at 251 nm.
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Figure 3 Plots of the retention time vs. methanol percentage in
the mobile phase of NOR, FLU and FVS.
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3.1. Optimization of the chromatographic conditions
During the analysis of drugs like NOR and FLU, one of the well
known problem in pharmaceutical industry is peak tailing. Since
these compounds strongly interact with polar ends of HPLC
column packing materials, causing severe peak asymmetry
and low separation efﬁciencies. High purity silica backbone
and advances in bonding technology have alleviated the
tailing problem of polar compounds in HPLC to a signiﬁcant
extent. During the optimization of the method, different col-
umns (Nucleodur C8, 250 mm  4.6 mm, 5 mm; Nucleodur C18,
250 mm  4.6 mm, 5 mm; Hypersil Gold C8, 250 mm  4.6
mm, 5 mm and ODS Hypersil C18, 250 mm  4.6 mm, 5 mm)
and two organic solvents (acetonitrile and methanol) were tested.
The chromatographic conditions were also optimized using
different buffers like phosphate, acetate and citrate for mobile
phase preparation. After a series of screening experiments, it was
concluded that formic acid gave better peak shapes than the
other buffers. With acetonitrile as solvent both the peaks showed
less theoretical plates and more retention time compared to
methanol. The chromatographic separation was achieved on a
Hypersil Gold C8 (250 mm  4.6 mm, 5 mm column) at 25 1C,
using a mixture of methanol–formic acid (0.1 M, pH 2.16; 67:33,
v/v) as mobile phase, and the peak shape of NOR, FLU and
FVS was found symmetrical (Fig. 2). The retention time of
NOR, FLU and FVS was 5.280, 8.320 and 11.793 min, respec-
tively. The effect of composition of the mobile phase and ﬂow rate
on the retention time of NOR, FLU and FVS, was investigated.
Results of the effect of methanol in the mobile phase are presented
in Fig. 3. An increase in the percentage of methanol decreases the
retention of compounds, namely, NOR, FLU and FVS. Increas-
ing methanol percentage to more than 70%NOR and FLU peaks
are eluted with the solvent front, while at methanol percentage
lower than 60% the elution of FLU peak is seriously delayed. The
optimummethanol percentage was found to be 67%. The effect of
pH in the chromatographic elution of the compounds was also
investigated by changing the concentration values of the aqueous
component of the mobile phase from 0.03 to 0.15 M. For all
experimental concentration values, the drugs are eluted in order ofNOR, FLU and FVS. A concentration value of 0.1 M HCOOH
was chosen for the optimum separation of the compounds, as at
this concentration the analyte peaks were well deﬁned and
resolved. The optimum wavelength for detection was at 251 nm,
at which the best detector responses for all substances were
obtained.
3.2. System suitability
The system suitability was determined by making seven
replicate injections and analyzing each solute for their peak
area, resolution and peak tailing factor. The system suitability
requirements for 75 mg/mL of NOR and 75 mg/mL of FLU in
the presence of 100 mg/mL of internal standard were a %RSD
for peak area less than 0.35, a peak tailing factor less than 1.2
and a resolution factor greater than 8.0 between adjacent
peaks for all analytes. This method met these requirements.
3.3. Linearity and limits of quantiﬁcation and detection
The calibration curves for NOR and FLU were linear over the
concentration range 5.0–1350.0 mg/mL and 10.0–1350.0 mg/mL,
respectively, as shown in Table 1. Correlation coefﬁcients (r) of
Table 1 Calibration data for the estimation of nortriptyline hydrochloride and ﬂuphenazine hydrochloride by HPLC.
Parameters Nortriptyline hydrochloride Fluphenazine hydrochloride
Optimum concentration range (mg/mL) 5.0–1350.0 10.0–1350.0
Regression equation
ANOR¼6.812CNORþ39.867 AFLU¼10.217CFLUþ7.824
Correlation coefﬁcient (n¼5) 0.9997 0.9998
Standard deviation of slope 0.015 0.034
Standard deviation of intercept 1.633 1.051
Regression equation
RNOR/FVS¼0.0063CNORþ0.0376 RFLU/FVS¼0.0094CFLUþ0.0082
Correlation coefﬁcient (n¼5) 0.9997 0.9998
Standard deviation of slope 0.0001 0.0003
Standard deviation of intercept 0.0028 0.0064
Limit of quantiﬁcation, LOQ (mg/mL) 2.41 1.04
Limit of detection, LOD (mg/mL) 0.72 0.31
nRegression equation for the peak area of drug vs. concentration of drug in mg/mL.
nnRegression equation for the ratio of peak area of drug to that of I.S. (FVS) vs. concentration of drug in mg/mL.
Table 2 Accuracy and precision of within and between run analysis for the determination of nortriptyline hydrochloride and
ﬂuphenazine hydrochloride by HPLC.
Compound Nominal concentration
(mg/mL)
Intra-day (n¼5) Intra-day (n¼5)
Mean7SD
(mg/mL)
RSD (%) Recovery (%) Mean7SD
(mg/mL)
RSD (%) Recovery (%)
Nortriptyline 5.00 5.0970.07 1.29 101.76 5.0870.06 1.27 101.56
35.00 35.7870.28 0.78 102.23 35.9770.41 1.14 102.77
75.00 77.0070.39 0.50 102.67 75.6870.79 1.04 100.91
150.00 151.4570.48 0.32 100.97 151.1271.44 0.95 100.75
300.00 311.7570.61 0.20 103.92 300.9072.56 0.85 100.30
900.00 917.5871.15 0.13 101.95 900.9176.57 0.73 100.10
1350.00 1350.5570.97 0.07 100.04 1355.5272.45 0.18 100.41
Fluphenazine 10.00 9.9970.06 0.64 99.90 9.9570.13 1.32 99.50
35.00 36.3470.21 0.59 103.82 35.3770.41 1.16 101.05
75.00 75.9370.32 0.43 101.24 75.0270.78 1.04 100.02
150.00 150.8170.49 0.32 100.54 151.2571.35 0.89 100.83
300.00 303.0570.73 0.24 101.02 300.9472.01 0.67 100.31
900.00 903.8071.84 0.20 100.42 899.7474.79 0.53 99.97
1350.00 1350.9872.49 0.18 100.07 1348.5471.90 0.14 99.89
S. Ashour, N. Kattan440the regression equations were greater than 0.999 in all cases.
The minimum level at which the investigated compounds can be
reliably detected (limit of detection, LOD) and quantiﬁed (limit
of quantitation, LOQ) was determined experimentally. The
LOD was expressed as the concentration of drug that generated
a response to three times of the signal-to-noise (S/N) ratio, and
the LOQ was 10 times of the S/N ratio. The LOD of NOR and
FLU attained as deﬁned by IUPAC [21], LOD(k¼3)¼kSa/b
(where b is the slope of the calibration curve and Sa is the
standard deviation of the intercept), was found to be 0.72 and
0.31 mg/mL, respectively. The LOQ was also attained according
to the IUPAC deﬁnition, LOQ(k¼10)¼kSa/b, and was found
to be 2.41 and 1.04 mg/mL, correspondingly.
3.4. Accuracy and precision
The precision and accuracy of the method were determined by
analysis of seven samples for drugs mixture. The speciﬁcity of thechromatographic method was determined to ensure separation of
NOR, FLU and the internal standard as shown in Fig. 2.
Intraday assay variation was evaluated by injecting these samples
in replicates of ﬁve in the same day. Interday assay variation was
evaluated by injecting these samples in replicates of ﬁve on 5
different days from 1 to 25 after preparation. The standard
deviation, relative standard deviation and recovery of different
amounts tested were determined. The accuracy of the method is
indicated by the excellent recovery and the precision is supported
by the low standard deviation, as recorded in Table 2.
3.5. Application of the assay
The performance of the proposed method was assessed by
comparison with the ofﬁcial method [4]. Mean values were
obtained with a Student’s t- and F-tests at 95% conﬁdence
limits for four degrees of freedom. The results showed
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Figure 4 A typical chromatogram of a mixture of NOR (900 mg/mL), FLU (45 mg/mL) and the internal standard, FVS (100 mg/mL) in
the mobile phase, prepared from Motival tablets. Chromatographic conditions: C8 column; mobile phase: 0.1 M formic acid and
methanol (33:67, v/v); ﬂow rate 1.1 mL/min and detection at 251 nm.
Table 3 Determination of nortriptyline hydrochloride and ﬂuphenazine hydrochloride in pharmaceutical formulations by the
proposed method and ofﬁcial method.
Sample Recovery (%)a7SD
Nortriptyline hydrochloride Fluphenazine hydrochloride
Proposed method Ofﬁcial method Proposed method Ofﬁcial method
Pure 100.1170.12 101.5070.17 100.6770.32 101.2970.54
t-value 1.89 2.04
F-value 2.00 2.85
ADIVAL (10 mg NOR and 0.5 mg FLU/tablet)
Mean7SDa 103.0770.59 100.7870.60 101.4070.69 100.3370.94
t-valueb 1.17 1.21 1.04 1.14
F-valueb 1.03 1.86
MOTIVAL (10 mg NOR and 0.5 mg FLU/tablet)
Mean7SDa 102.8770.39 100.6570.27 102.8270.82 101.0870.70
t-valueb 1.37 1.09 1.24 1.33
F-valueb 2.09 1.37
NORTIVAL (10 mg NOR and 0.5 mg FLU/tablet)
Mean7SDa 104.8470.74 103.9470.51 103.5070.49 102.2070.36
t-valueb 0.97 1.84 1.28 1.47
F-valueb 2.11 1.85
aFive independent analyses.
bTheoretical values for t and F-values at ﬁve degree of freedom and 95% conﬁdence limit are t ¼2.776 and F¼6.26.
Simultaneous determination of nortriptyline hydrochloride and ﬂuphenazine hydrochloride by HPLC-UV 441comparable accuracy (t-test) and precision (F-test), since the
calculated values of t- and F-tests were less than the theoretical
data. The proposed procedures were applied to determine
NOR and FLU in their pharmaceutical formulations (Fig. 4).
The results in Table 3 indicate the high accuracy and
precision. As can be seen from Table 3, the proposed method
has the advantages of being virtually free from interferences
by excipients such as glucose, lactose and starch or fromcommon degradation products. The results obtained were
compared statistically by the Student’s t-test (for accuracy)
and the variance ratio F-test (for precision) with those
obtained by the ofﬁcial method for the samples of the same
batch (Table 3). The values of t- and F-tests obtained at
95% conﬁdence level did not exceed the theoretical tabulated
value indicating no signiﬁcant difference between the methods
compared.
S. Ashour, N. Kattan4424. Conclusion
Conclusively, the HPLC method described in this paper is
speciﬁc, sensitive, rapid and easy to perform. The proposed
method enables simultaneous determination of nortriptyline
hydrochloride and ﬂuphenazine hydrochloride using ﬂuvastatin
sodium as internal standard with good separation and resolution
of the chromatographic peaks. The sample recoveries from all
formulations were in good agreement with their respective label
claims, which suggested non-interference of formulations excipi-
ents in the estimation. Moreover, the present method is fast with
respect to analysis time as compared to sophisticated spectro-
photometric techniques. The method provided excellent speciﬁ-
city and linearity with a limit of quantiﬁcation of 2.41 and
1.04 mg/mL and limit of detection of 0.72 and 0.31 mg/mL for
NOR and FLU, respectively. The major advantage of this
method is the wide range of linearity.References
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